Announcement
28 Sep 2021
On 28 September 2021, the EIB provided financing worth EUR 15 million (USD 18 million) to support Dutch company Xeltis' research and development (R&D) investments related to cardiovascular therapy and implantable cardiovascular devices.
Source
Sign in to access
Number of interventions
2
2 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
28 Sep 2021
Revocation date:
No revocation date
Updated: 28 Sep 2021
Loan guarantee
In force
The EIB's EUR 15 million (approx. USD 18 million) loan to Xeltis signed on 28 September 2021 was backed by a guarantee from the Pan-European Guarantee Fund (EGF).
The EGF was crea...
Sign in to see more
Updated: 28 Sep 2021
State loan
In force
On 28 September 2021, the European Investment Bank (EIB) and Dutch company Xeltis Bv signed an agreement worth EUR 15 million (approx. USD 18 million) to support the company's resear...
Sign in to see more
Related State Acts
Threads
See all
This state act is not part of any Thread yet.